R.M.E. Vos

976 total citations
30 papers, 830 citations indexed

About

R.M.E. Vos is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, R.M.E. Vos has authored 30 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Pharmacology and 6 papers in Organic Chemistry. Recurrent topics in R.M.E. Vos's work include Pharmacogenetics and Drug Metabolism (13 papers), Glutathione Transferases and Polymorphisms (11 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). R.M.E. Vos is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Glutathione Transferases and Polymorphisms (11 papers) and Genomics, phytochemicals, and oxidative stress (9 papers). R.M.E. Vos collaborates with scholars based in Netherlands, United States and Sweden. R.M.E. Vos's co-authors include Peter J. van Bladeren, L. P. C. Delbressine, Carole Verhoeven, Ben van Ommen, Willem J. H. van Berkel, J.H.T.M. Ploemen, Ivonne M.C.M. Rietjens, Jan J.P. Bogaards, Franz Müller and Erifili Mosialou and has published in prestigious journals such as Journal of Biological Chemistry, Biological Psychiatry and European Journal of Biochemistry.

In The Last Decade

R.M.E. Vos

30 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.M.E. Vos Netherlands 16 423 198 103 98 93 30 830
Monique Vincent‐Viry France 18 327 0.8× 200 1.0× 114 1.1× 64 0.7× 219 2.4× 40 1.0k
Rhys Whomsley Belgium 17 211 0.5× 210 1.1× 61 0.6× 118 1.2× 56 0.6× 36 928
Eric Sérée France 21 414 1.0× 265 1.3× 76 0.7× 62 0.6× 83 0.9× 31 1.1k
Lucie Stejskalová Czechia 9 313 0.7× 201 1.0× 78 0.8× 50 0.5× 93 1.0× 11 947
G A Hazelton United States 17 282 0.7× 252 1.3× 37 0.4× 58 0.6× 51 0.5× 25 922
Adelbert E. Wade United States 17 246 0.6× 314 1.6× 59 0.6× 71 0.7× 87 0.9× 53 866
Tetsuya Kamataki Japan 16 364 0.9× 589 3.0× 130 1.3× 71 0.7× 67 0.7× 22 961
Joyce Massengill United States 7 358 0.8× 268 1.4× 83 0.8× 76 0.8× 21 0.2× 9 822
Ruth E. Billings United States 22 436 1.0× 338 1.7× 37 0.4× 140 1.4× 73 0.8× 51 1.4k
Claire Belloc France 13 225 0.5× 519 2.6× 66 0.6× 103 1.1× 45 0.5× 15 789

Countries citing papers authored by R.M.E. Vos

Since Specialization
Citations

This map shows the geographic impact of R.M.E. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.M.E. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.M.E. Vos more than expected).

Fields of papers citing papers by R.M.E. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.M.E. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.M.E. Vos. The network helps show where R.M.E. Vos may publish in the future.

Co-authorship network of co-authors of R.M.E. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of R.M.E. Vos. A scholar is included among the top collaborators of R.M.E. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.M.E. Vos. R.M.E. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verhoeven, Carole, Tino Münster, Geny M. M. Groothuis, R.M.E. Vos, & Ivonne M.C.M. Rietjens. (2002). Identification of the human P450 enzymes involved in thein vitrometabolism of the synthetic steroidal hormones Org 4060 and Org 30659. Xenobiotica. 32(2). 109–118. 2 indexed citations
2.
Vos, R.M.E., et al.. (2002). The in Vivo Human Metabolism of Tibolone. Drug Metabolism and Disposition. 30(2). 106–112. 75 indexed citations
3.
Verhoeven, Carole, R.M.E. Vos, & L. P. C. Delbressine. (2002). The in vivo metabolism of tibolone in animal species. European Journal of Drug Metabolism and Pharmacokinetics. 27(1). 1–10. 20 indexed citations
4.
Shi, Juan, Robert Van Horn, William R. Brian, et al.. (2002). Fondaparinux Sodium Is Not Metabolised in Mammalian Liver Fractions and Does Not Inhibit Cytochrome P450-Mediated Metabolism of Concomitant Drugs. Clinical Pharmacokinetics. 41(Supplement 2). 19–26. 25 indexed citations
5.
Verhoeven, Carole, et al.. (2001). Excretion and metabolism of desogestrel in healthy postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 78(5). 471–480. 9 indexed citations
6.
Verhoeven, Carole, et al.. (2000). Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women. The Journal of Steroid Biochemistry and Molecular Biology. 73(1-2). 39–48. 2 indexed citations
7.
Verhoeven, Carole, et al.. (1998). In vitro and in vivo metabolism of desogestrel in several species.. PubMed. 26(9). 927–36. 18 indexed citations
8.
Delbressine, L. P. C. & R.M.E. Vos. (1997). The Clinical Relevance of Preclinical Data. Journal of Clinical Psychopharmacology. 17. 29S–33S. 28 indexed citations
9.
Onderwater, Rob, Arnold R. Goeptar, R.M.E. Vos, et al.. (1996). The Use of Macroporous Microcarriers for the Large-Scale Growth of V79 Cells Genetically Designed to Express Single Human Cytochrome P450 Isoenzymes and for the Characterization of the Expressed Cytochrome P450. Protein Expression and Purification. 8(4). 439–446. 8 indexed citations
10.
Mosialou, Erifili, Fiorella Piemonte, Claes Andersson, et al.. (1995). Microsomal glutathione transferase: Lipid-derived substrates and lipid dependence. Archives of Biochemistry and Biophysics. 320(2). 210–216. 72 indexed citations
11.
12.
13.
Bladeren, Peter J. van, Ben van Ommen, & R.M.E. Vos. (1990). Toxication reactions catalysed by GST: inhibition of GST by reactive conjugates.. Socio-Environmental Systems Modeling. 131–140. 1 indexed citations
14.
Ommen, Ben van, J.H.T.M. Ploemen, Hendrik J.T. Ruven, et al.. (1989). Studies on the active site of rat glutathione S‐transferase isoenzyme 4–4. European Journal of Biochemistry. 181(2). 423–429. 39 indexed citations
15.
Bruggeman, I.M., et al.. (1989). Use of monolayers of primary rat kidney cortex cells for nephrotoxicity studies. Toxicology in Vitro. 3(4). 261–269. 23 indexed citations
16.
Vos, R.M.E., et al.. (1989). Methyl linoleate ozonide as a substrate for rat glutathione S-transferases: Reaction pathway and isoenzyme selectivity. Chemico-Biological Interactions. 69(2-3). 269–278. 15 indexed citations
17.
Vos, R.M.E., et al.. (1989). Irreversible inhibition of rat hepatic glutathione S-transferase isoenzymes by a series of structurally related quinones. Chemico-Biological Interactions. 71(4). 381–392. 25 indexed citations
18.
Roszkowski, Wojciech, et al.. (1989). Digestibility of casein, formaldehyde-treated casein and soya-bean protein in relation to their effects on serum cholesterol in rabbits. British Journal Of Nutrition. 62(2). 331–342. 8 indexed citations
19.
Vos, R.M.E., et al.. (1988). Differential induction of rat hepatic glutathione S-transferase isoenzymes by hexachlorobenzene and benzyl isothiocyanate. Biochemical Pharmacology. 37(6). 1077–1082. 69 indexed citations
20.
Vos, R.M.E., et al.. (1987). Methyl linoleate ozonide: A substrate for rat glutathione S-transferases. European Journal of Drug Metabolism and Pharmacokinetics. 12(4). 275–277. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique Vincent‐Viry Breakdown of academic impact, for papers by Rhys Whomsley Breakdown of academic impact, for papers by Eric Sérée Breakdown of academic impact, for papers by Lucie Stejskalová Breakdown of academic impact, for papers by G A Hazelton Breakdown of academic impact, for papers by Adelbert E. Wade Breakdown of academic impact, for papers by Tetsuya Kamataki Breakdown of academic impact, for papers by Joyce Massengill Breakdown of academic impact, for papers by Ruth E. Billings Breakdown of academic impact, for papers by Claire Belloc
Rankless by CCL
2026